GlassScriptPhysician profile
Frances Connie Lee
NPI 1669834024
$407.93
in general payments reported to CMS, 2019-2025
6 companies · $34.23 in 2025
The $34.23 reported for 2025 was less than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $244 · 2024: $129 · 2025: $34.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $407.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $198.48 | 2023-2024 | |
| Nestle Healthcare Nutrition INC. | $53.55 | 2023 | |
| Ipsen Biopharmaceuticals, INC | $50.63 | 2024 | Iqirvo, Bylvay |
| Qol Medical, LLC | $48.40 | 2023-2024 | Sucraid, Sucraid |
| Alcresta Therapeutics, INC. | $34.23 | 2025 | Relizorb |
| Albireo Pharma, INC. | $22.64 | 2023 | Bylvay |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frances Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.